MLR
The mineralocorticoid receptor (MR) belongs to the steroid receptor superfamily together with receptors for progesterone, estrogens, androgens and glucocorticoids. In classical target tissues like epithelia of the kidney, colon, sweat and salivary glands, the MR is activated by aldosterone and subsequently increases sodium and water reabsorption, enhanced potassium secretion and thereby contributes to the maintenance of blood pressure. The MR is expressed abundantly in the limbic brain where it surprisingly was found to mediate predominantly the action of the naturally occurring glucocorticoids cortisol and corticosterone. MR is expressed in cells of nonepithelial tissue like heart and vasculature, where it can lead to pathophysiological changes initiated by inflammation or an altered micromilieu followed by fibrosis, hypertrophy and remodeling. There is an intense cross-talk between MR outside the nucleus and other signaling components that is crucial for its non-canonical actions. These interactions include different membrane receptors, namely receptor tyrosine kinases and the angiotensin 1 receptor. Activation of these receptors occurs not only by binding of ligands but also by a mechanism called transactivation, the receptor tyrosine kinases considered are epidermal growth factor receptor (EGFR), insulin receptor (IR)/insulin-like growth factor receptor (IGF-1 receptor), platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR).
References
1.Meinel S, et al. Steroids. 2014;91:3–10.
References
1.Meinel S, et al. Steroids. 2014;91:3–10.
Nuclear Receptor/Transcription Factor
MLR
-
Apararenone
产品货号 : M16779
cas no: 945966-46-1
Apararenone (MT-3995) 是一种新型强效、选择性非甾体盐皮质激素受体拮抗剂,用于治疗糖尿病肾病和非酒精性脂肪性肝炎。 -
AZD 9977
产品货号 : M12858
cas no: 1850385-64-6
AZD9977 是一种新型、一流、选择性口服盐皮质激素受体 (MR) 调节剂,pKi 为 7.5,对 GR、PR 和 AR 几乎没有亲和力 (pIC50<5.5)。 -
CS-3150
产品货号 : M12453
cas no: 1632006-28-0
CS-3150 (Esaxerenone, XL-550) 是一种高效、选择性、口服活性的非甾体盐皮质激素受体拮抗剂,IC50 为 9.4 nM。 -
KBP-5074
产品货号 : M11476
cas no: 1359969-26-8
KBP-5074 (KBP5074) 是一种新型非甾体类、高选择性盐皮质激素受体拮抗剂,用于治疗高血压慢性肾病。 -
Finerenone
产品货号 : M10243
cas no: 1050477-31-0
Finerenone (BAY 94-8862) 是一种有效的、选择性的、口服的盐皮质激素受体 (MR) 拮抗剂,IC50 为 18 nM。